International Assets Investment Management LLC Acquires Shares of 10,177 Bath & Body Works, Inc. (NYSE:BBWI)

International Assets Investment Management LLC purchased a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 10,177 shares of the company’s stock, valued at approximately $439,000.

Other institutional investors have also modified their holdings of the company. Shell Asset Management Co. boosted its stake in shares of Bath & Body Works by 180.0% during the 3rd quarter. Shell Asset Management Co. now owns 56,344 shares of the company’s stock worth $1,904,000 after acquiring an additional 36,222 shares in the last quarter. Pearl River Capital LLC boosted its stake in shares of Bath & Body Works by 145.6% during the 3rd quarter. Pearl River Capital LLC now owns 31,364 shares of the company’s stock worth $1,060,000 after acquiring an additional 18,596 shares in the last quarter. Aigen Investment Management LP purchased a new stake in shares of Bath & Body Works during the 3rd quarter worth approximately $1,697,000. Vanguard Group Inc. boosted its stake in shares of Bath & Body Works by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 25,689,543 shares of the company’s stock worth $868,307,000 after acquiring an additional 67,920 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. purchased a new stake in shares of Bath & Body Works during the 3rd quarter worth approximately $1,550,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

Shares of BBWI opened at $45.60 on Friday. The stock has a fifty day moving average of $46.21 and a two-hundred day moving average of $40.43. The company has a market capitalization of $10.26 billion, a PE ratio of 11.84, a price-to-earnings-growth ratio of 1.46 and a beta of 1.86. Bath & Body Works, Inc. has a fifty-two week low of $27.30 and a fifty-two week high of $50.34.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Thursday, February 29th. The company reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.21. The company had revenue of $2.91 billion during the quarter, compared to the consensus estimate of $2.84 billion. Bath & Body Works had a negative return on equity of 37.01% and a net margin of 11.82%. Bath & Body Works’s revenue was up .8% on a year-over-year basis. During the same period in the previous year, the firm posted $1.86 EPS. As a group, equities research analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 8th. Stockholders of record on Friday, February 23rd were issued a dividend of $0.20 per share. The ex-dividend date was Thursday, February 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.75%. Bath & Body Works’s payout ratio is 20.78%.

Insider Transactions at Bath & Body Works

In other news, insider Thomas E. Mazurek sold 4,285 shares of the company’s stock in a transaction on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total transaction of $209,493.65. Following the completion of the sale, the insider now directly owns 45,992 shares in the company, valued at approximately $2,248,548.88. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.19% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on BBWI shares. Evercore ISI boosted their price target on Bath & Body Works from $30.00 to $45.00 and gave the stock an “in-line” rating in a research note on Friday, March 1st. BMO Capital Markets lifted their price objective on Bath & Body Works from $48.00 to $50.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. Wells Fargo & Company lifted their price objective on Bath & Body Works from $42.00 to $48.00 and gave the stock an “equal weight” rating in a research report on Wednesday. UBS Group lifted their price objective on Bath & Body Works from $46.00 to $52.00 and gave the stock a “neutral” rating in a research report on Monday, March 4th. Finally, The Goldman Sachs Group lifted their price objective on Bath & Body Works from $49.00 to $56.00 and gave the stock a “buy” rating in a research report on Monday, March 4th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, Bath & Body Works has an average rating of “Hold” and a consensus price target of $46.73.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.